Surgery Doctors in Lawrenceburg, IN Accepting Medicare

5 Surgery doctors found. Showing 1 - 5

Dr. Alexis Armour, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Medicare Enrolled Practice Location: 368 Bielby Rd, Lawrenceburg, IN 47025 Phone: 812-537-8350    Fax: 812-537-3710

Brianne N. Runyan, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 368 Bielby Rd, Lawrenceburg, IN 47025 Phone: 812-496-8771    Fax: 812-537-3936

Dr. Steven Samuel Weber, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 368 Bielby Rd, Lawrenceburg, IN 47025 Phone: 513-686-5455    Fax: 513-686-5469

Michael E Mcandrew, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 368 Bielby Rd, Suite 100, Lawrenceburg, IN 47025 Phone: 812-537-5772    Fax: 812-537-3936

Mark R Mcandrew, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 368 Bielby Rd, Suite 100, Lawrenceburg, IN 47025 Phone: 812-537-5772    Fax: 812-537-3936

News Archive

New study enrolls young adults to evaluate SARS-CoV-2 infection

The Prevent COVID U study, which launched in late March 2021 to evaluate SARS-CoV-2 infection and transmission among university students vaccinated with the Moderna COVID-19 Vaccine, has expanded beyond the university setting to enroll young adults ages 18 through 29 years and will now also include people in this age group who choose not to receive a vaccine.

DNA sequencing helps detect MRSA outbreaks in hospitals

This study used DNA sequencing to examine an outbreak of MRSA in a hospital, to uncover new cases and, as the study developed, to intervene in the outbreak to end it more quickly. Sequencing illuminated each person infected and described the transmission of MRSA between people coming to the hospital and within the hospital.

TenX Biopharma recommences enrollment in suspended Phase III trial for cutaneous T-cell lymphoma

TenX Biopharma, Inc. announced today that it has re-initiated enrollment in the pivotal Phase III clinical trial assessing zanolimumab treatment for cutaneous T-cell lymphoma (CTCL) patients (ClinicalTrials.gov identifier: NCT00127881). The trial enrollment was suspended in October 2008 while Genmab was seeking a out-license agreement to further develop the compound. TenX Biopharma acquired global rights to zanolimumab in February, 2010 from Genmab.

Nasal surgery improves quality of life for those with obstructive sleep apnea

Nasal surgery to remove obstructions from the airway is associated with improvements in quality of life for patients with obstructive sleep apnea and symptoms of nasal blockages, according to a report in the April issue of Archives of Otolaryngology-Head & Neck Surgery.

Read more Medical News

› Verified 8 days ago